Health ❯ Healthcare ❯ Cardiovascular Health

Risk Factors

Blood Pressure Management Hypertension Weight Management Diabetes Left Ventricle Mass Lifestyle Interventions Alcohol Consumption Glycemic Control Cardiovascular Disease Hypertension Treatment

Retatrutide Drives Unusually Large Weight Loss in People With Type 2 Diabetes

Regulators will now review whether the triple‑agonist’s large weight and blood‑sugar reductions translate into lasting health benefits.

Novartis' Pelacarsen Fails Phase 3 After Lowering Lp(a)

World Hypertension Day Spurs Local Screenings as Silent High Blood Pressure Rises in Young People

Anvisa Halts Specific Lots of Cimed Statins and Hypofarma Dexamethasone

Women’s Heart Risk Rises at Lower Coronary Plaque Burden in PROMISE CCTA Analysis

Oral Semaglutide 25 mg Shows Larger Metabolic Gains With At Least 15% Weight Loss in OASIS-4

Ventyx’s NLRP3 Drug Cuts Inflammation Markers in Phase 2, Shares Soar

Orforglipron Pill Cuts Weight 11–12% in Pivotal Phase 3 Trial

Orforglipron Phase 3 Results Published, Show Promise as Oral GLP-1 Option for Obesity

Four in Ten Argentine Adults Have High Cholesterol, UBA Clinicians Warn

New U.S. Blood Pressure Guidelines Urge Earlier Treatment as Study Backs Lower Targets

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

Hypertension Canada Releases New Guideline for Primary Care Management

MRI Scans Found to Predict Heart Disease Risk a Decade in Advance

Diabetes and Obesity Drugs Found to Protect Kidney Health